Loading insider details...
Beta
Latest Form 4 (Oct 6, 2026): Exercise/Conversion of 340 LGND shares, $17.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 6, 2026 | LIGAND PHARMACEUTICALS INC (LGND) | Exercise/Conversion | 340 | $17.8K |
| Sep 8, 2026 | LIGAND PHARMACEUTICALS INC (LGND) | Sale | 300 | $85.2K |
| Aug 4, 2026 | LIGAND PHARMACEUTICALS INC (LGND) | Exercise/Conversion | 5,000 | $261.4K |
| Jul 6, 2026 | LIGAND PHARMACEUTICALS INC (LGND) | Other (see footnotes) | 132 | $21.2K |
| Jun 2, 2026 | LIGAND PHARMACEUTICALS INC (LGND) | Exercise/Conversion | 5,000 | $261.4K |
| May 5, 2026 | LIGAND PHARMACEUTICALS INC (LGND) | Exercise/Conversion | 5,000 | $261.4K |
| Apr 2, 2026 | LIGAND PHARMACEUTICALS INC (LGND) | Exercise/Conversion | 5,000 | $261.4K |
| Mar 28, 2026 | LIGAND PHARMACEUTICALS INC (LGND) | Grant/Award | 4,513 | n/a |
| Mar 6, 2026 | LIGAND PHARMACEUTICALS INC (LGND) | Exercise/Conversion | 5,000 | $261.4K |
| Feb 18, 2026 | LIGAND PHARMACEUTICALS INC (LGND) | Grant/Award | 6,928 | n/a |